Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites

Hepatology

Volumn 37, Issue 4, 2003, Pages 897-901

  Evans, Luke T ^a   Kim, W Ray ^a   Poterucha, John J ^a   Kamath, Patrick S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CEFOTAXIME; CIPROFLOXACIN; METRONIDAZOLE; TROVAFLOXACIN;

ADULT; AGED; ARTICLE; ASCITES; ASCITES FLUID; BACTERIAL PERITONITIS; BACTERIUM CULTURE; CELL COUNT; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GRAM POSITIVE BACTERIUM; HEPATORENAL SYNDROME; HOSPITALIZATION; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHIL; OUTPATIENT; PARACENTESIS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0037382870     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50119     Document Type: Article

References (18)

1. Silvain C, Besson I, Ingrand P, Mannant PR, Fort E, Beauchant M. Prognosis and long-term recurrence of spontaneous bacterial peritonitis in cirrhosis. J Hepatol 1993;19:188-189.
2. Tito L, Rimola A, Gines P, Llach J, Arroyo V, Rodes J. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. HEPATOLOGY 1988;8:27-31.
3. Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francitorra A, Rimola A, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. HEPATOLOGY 1994;20:1495-1501.
4. Runyon BA. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology 1986;91:1343-1346.
5. Almdal TP, Skinhoj P. Spontaneous bacterial peritonitis in cirrhosis. Incidence, diagnosis, and prognosis. Scand J Gastroenterol 1987;22:295-300.
6. Pinzello G, Simonetti RG, Craxi A, Di Piazza S, Spano C, Pagliaro L. Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients. HEPATOLOGY 1983;3:545-549.
7. Jeffries MA, Stern MA, Gunaratnam NT, Fontana RJ. Unsuspected infection is infrequent in asymptomatic outpatients with refractory ascites undergoing therapeutic paracentesis. Am J Gastroenterol 1999;94:2972-2976.
8. Runyon BA. Management of adult patients with ascites caused by cirrhosis. HEPATOLOGY 1998;27:264-272.
9. Kolle L, Ortiz J, Ricart E, Sabat M, Sola-Vera J, Soriano G, Guarner C, et al. Ascitic fluid culture is not necessary in asymptomatic cirrhotic outpatients undergoing repeated therapeutic paracentesis. HEPATOLOGY 1996;24:445A.
10. Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, Inadomi JM. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 2000;32:142-153.
11. Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology 1988;95:1351-1355.
12. Runyon BA, Umland ET, Merlin T. Inoculation of blood culture bottles with ascitic fluid. Improved detection of spontaneous bacterial peritonitis. Arch Intern Med 1987;147:73-75.
13. Kamath PS, Wiesner RH, Malinchoc M, Kremers WK, Therneau TM, Kosberg CL, Dickson ER, et al. A model to predict survival in patients with end-stage liver disease. HEPATOLOGY 2001;33:464-470.
14. Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. HEPATOLOGY 1996;23:164-176.
15. Sort P, Navasa M, Arroyo V, Adeguer X, Planas R, Ruiz-del-Arbol L, Castells L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341:403-409.
16. Runyon BA. Monomicrobial non-neutrocytic bacterascites: a variant of spontaneous bacterial peritonitis. HEPATOLOGY 1990;12:710-715.
17. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, Rodes J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. HEPATOLOGY 2002;35:140-148.
18. Malinchoc M, Gines P, Navasa M, Fernandez J, Kim WR, Wiesner RH, Kamath PS. The Model for End-stage Liver Disease (MELD) score predicts survival in patients with spontaneous bacterial peritonitis, and with ascites. Gastroenterology 2001;120:A378.